Cargando…
Anabolic therapy for osteoporosis: update on efficacy and safety
Anabolic agents for the treatment of osteoporosis increase bone density, improve bone strength, and reduce fracture risk. They are distinguished from antiresorptive drugs by their property of increasing osteoblastic bone formation. Teriparatide and abaloparatide are parathyroid hormone receptor agon...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118815/ https://www.ncbi.nlm.nih.gov/pubmed/36382760 http://dx.doi.org/10.20945/2359-3997000000566 |